VALIANT CAPITAL MANAGEMENT, L.P. – CRISPR Therapeutics AG Transaction History
VALIANT CAPITAL MANAGEMENT, L.P. portfolio value:
$12.42M
portfolio value
VALIANT CAPITAL MANAGEMENT, L.P. quarter portfolio value change:
+7.54%
quarter
CRISPR Therapeutics AG 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -41.26% | -133.6K shares | -7.24M | $65.35 | 190.18K |
| Q2 2022 | share | Increase | +34.53% | 83.1K shares | 4.56M | $60.77 | 323.78K |
| Q1 2022 | share | Increase | +35.30% | 62.8K shares | 1.62M | $62.77 | 240.68K |
| Q4 2021 | share | Decrease | -42.19% | -129.81K shares | -20.96M | $78.85 | 177.88K |
| Q3 2021 | share | 0.00% | 0 shares | -15.37M | $111.93 | 307.7K | |
| Q2 2021 | share | 0.00% | 0 shares | 12.32M | $161.89 | 307.7K | |
| Q1 2021 | share | Decrease | -13.37% | -47.5K shares | -16.89M | $121.85 | 307.7K |
| Q4 2020 | share | Decrease | -24.13% | -113K shares | 15.22M | $153.11 | 355.2K |
| Q3 2020 | share | 0.00% | 0 shares | 4.75M | $83.64 | 468.2K | |
| Q2 2020 | share | 0.00% | 0 shares | 14.55M | $73.49 | 468.2K | |
| Q1 2020 | share | Increase | +72.32% | 196.5K shares | 3.30M | $42.41 | 468.2K |
| Q4 2019 | share | 0.00% | 0 shares | 5.41M | $60.91 | 271.7K | |
| Q3 2019 | share | 0.00% | 0 shares | -1.66M | $40.99 | 271.7K | |
| Q2 2019 | share | 0.00% | 0 shares | 3.09M | $47.1 | 271.7K | |
| Q1 2019 | share | 0.00% | 0 shares | 1.94M | $35.72 | 271.7K | |
| Q4 2018 | share | 0.00% | 0 shares | -4.28M | $28.57 | 271.7K | |
| Q3 2018 | share | Increase | 0.00% | 271.7K shares | 12.05M | $44.35 | 271.7K |